Nice research in the last couple of posts matrix, cheers

First 2 Last

Share
Profile

Follow
Bluebush

2,303 Posts.

327

01/02/15

17:09

Post #: 14677981
Share

Originally posted by mattrix ↑

The IT person at SUDA should be commended for the way in which the website is continually being updated. I haven't looked at it for a while but was pleased to see the recent updates. As announcement are made, if they are relevant they are quickly included. One recent addition is the Intellectual Property which provided further insight as to what products could be targeted in the future. Just reading through some of these could be quite significant in terms of dollar value.

Intellectual Property

SUDA's intellectual property includes granted and pending patents, trademarks and proprietary know-how. The patent estate covers liquid spray formulations of over 300 Active Pharmaceutical Ingredients (APIs) from a wide range of drug classes such as anti-infectives, (i.e. antibiotics and antifungals), anti-asthmatics, barbiturates, opioids as well as biologically active peptides hormones such as, insulin and cyclosporine. These formulations can be administered to the oral cavity in the form of a micro-mist that covers the oral mucosal membranes. The management intends to strengthen the intellectual property portfolio as it progresses with its R&D efforts.

Interestingly PYL put out an announcement last week regarding using the transbuccal delivery method as the preferred way of administering medical marijuana. SUDA makes reference in the above statement regarding barbiturates and opioids. This can only add further support to SUDA's delivery platform. I particularly like the use of "state of the art delivery system."

Yaacov Michlin, CEO of Yissum, stated: “We are very pleased to collaborate with PhytoTech in
developing the inventions of Professors Domb and Hoffman for the purpose of delivering the active
components in cannabis. Medical cannabis is increasingly being used for a variety of indications,
such as reducing nausea during chemotherapy and relieving pain and muscle spasticity in MS
patients. Development of state-of-the art delivery systems for the active ingredients will undoubtedly
pave the way for a wider variety of clinical indications for these types of drugs.”
“We are happy to collaborate with Yissum in developing this novel delivery platform for THC and
CBD,” said Boaz Wachtel, Managing Director of PhytoTech Medical. “We believe that Yissum’s
novel transbuccal delivery method is particularly appropriate for the delivery of these agents, and
helps avoid problems such as lack of standardization of drug concentration, and health risks
stemming from more traditional ways of absorbing cannabis, such as smoking.”

Expand

Nice research in the last couple of posts matrix, cheers

SUD Price at posting: 4.1¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

There are more pages in this discussion • 1 more message in this thread...

First 2 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 14.0¢		Change 0.000(0.00%)		Mkt cap ! $147.1M

Open	High	Low	Value	Volume
14.5¢	14.5¢	14.0¢	$82.82K	582.9K

Buyers (Bids)

No.	Vol.	Price($)
12	514820	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
14.5¢	431957	7

View Market Depth

No.	Vol.	Price($)
12	514820	0.140
9	330868	0.135
10	616104	0.130
8	691879	0.125
11	791339	0.120

Price($)	Vol.	No.
0.145	431957	7
0.150	636710	6
0.155	88709	3
0.160	1471739	5
0.165	322812	1

Last trade - 16.10pm 10/07/2024 (20 minute delay)

ALA (ASX) Chart

Nice research in the last couple of posts matrix, cheers

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nice research in the last couple of posts matrix, cheers

Top Stories

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News